ACR 8.33% 6.5¢ acrux limited

lilly to acquire global license to axiron, page-15

  1. 89 Posts.
    You guys maybe missing the point here.
    The bit in the announcement that is worth noting is the areas that Axiron wasn't necessarily developed for, but can be used - ie diabeties, obesity. This is a BLOCKBUSTER product.
    It will be used for a whole range of ailments and conditions - some known, some unknown as yet. Feeling tired? Depressed? Axiron. Low libido? Axiron. Overweight? Axiron. If you can appreciate the level of (over) prescription of anti-depresants and stimulants - then you can start to get an appreciation as to what Axiron can do. Plus, testosterone is natural! Not a foreign chemical.So the resistance to take up will be a whole lot less with , I suspect none of the bad press surrounding the alternatives.

    Just as Viagra was initially developed for a heart problems and then found a willing market elsewhere, so to will Axiron be used by physicians to deal with a whole slew of ailments.

    Lilly knows this and is backing itself to make over $1b in revenue from this over the next 3 years. This will be the biggest deal in Australian biotech for at least a decade. When they talk about better news to come, they are really saying EVEN Better news. Enjoy the upside fella's this is a long term growth stock. My prediction is well in excess of $3.50, but either way we are holding this baby for the long term now.
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.5¢
Change
0.005(8.33%)
Mkt cap ! $18.89M
Open High Low Value Volume
6.4¢ 6.5¢ 6.4¢ $3.399K 53.06K

Buyers (Bids)

No. Vol. Price($)
1 50000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 70395 1
View Market Depth
Last trade - 15.57pm 11/07/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.